Search Results for: chronic plaque psoriasis

October 27, 2016

Otezla Receives Key NICE Recommendation for Adult Patients with Chronic Plaque Psoriasis in England, Wales

News

The National Institute for Health and Care Excellence (NICE) has issued a positive final appraisal recommending the use of Celgene’s Otezla (apremilast) for adult patients with chronic plaque psoriasis in ... Read more

April 28, 2016April 28, 2016

Phase 1 Trial for Chronic Plaque Psoriasis Treatment Launched by Exicure

News

Exicure, a company developing a new class of immunomodulatory and gene-silencing drugs including Spherical Nucleic Acid (SNA), has just announced the dosing of the first patient in its Phase 1 ... Read more

Cyltezo for Psoriatic Arthritis and Plaque Psoriasis

Cyltezo (adalimumab-admb) is a drug from Boehringer Ingelheim Pharmaceuticals for the treatment of chronic inflammatory diseases, including psoriatic arthritis and plaque psoriasis. Cyltezo is a biosimilar to Humira, which has been approved ... Read more

May 30, 2017May 30, 2017

FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis

News

The U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for Sun Pharmaceutical’s lead investigational drug tildrakizumab to treat moderate-to-severe plaque psoriasis. Merck, which since 2014 has ... Read more

May 11, 2017

Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target

News

An already started Phase 2b clinical trial of Prurisol as a treatment for moderate-to-severe chronic plaque psoriasis has recruited more than 70 percent of the 189 participants that researchers hoped for. The ... Read more

April 18, 2017April 18, 2017

National Psoriasis Foundation Grants Seal of Recognition to MetaDerm Heal & Prevent Psoriasis Cream

News

The National Psoriasis Foundation (NPF) has given its Seal of Recognition to MetaDerm Heal & Prevent Cream, a therapeutic botanical cream for psoriasis made by Haus Bioceuticals. MetaDerm — one of the first botanical-based therapeutic products to ... Read more

April 4, 2017April 4, 2017

FDA Adds Fingernail Psoriasis to Prescribing Information for AbbVie’s Humira Therapy

News

The U.S. Food and Drug Administration (FDA) has approved the inclusion of fingernail psoriasis in prescribing information for Humira (adalimumab, AbbVie) a drug used by patients with moderate to severe chronic ... Read more

March 28, 2017March 28, 2017

EU Approves Amgevita for Treatment of Plaque Psoriasis, Other Inflammatory Diseases

News

The European Union has approved Amgen’s Amgevita (a biosimilar to AbbVie’s Humira, adalimumab) to treat moderate to severe chronic plaque psoriasis, as well as other inflammatory diseases. This EU approval follows a positive opinion ... Read more

March 16, 2017March 16, 2017

MetrioPharm Reports Positive Phase 2a Trial Results of MP1032 for Plaque Psoriasis

News

MetrioPharm reported positive results from a Phase 2a clinical trial evaluating its drug candidate MP1032 in patients with moderate to severe plaque psoriasis, and now plans to conduct a Phase ... Read more

March 7, 2017

Otezla Found Superior to Placebo in Treating Moderate Plaque Psoriasis, Celgene Reports

News

Celgene reported positive results from its Phase 4 UNVEIL clinical trial that evaluated Otezla (apremilast) in patients with moderate plaque psoriasis with a body surface area (BSA) of 5-10%. The results were ... Read more